Anvisa aprova novo tratamento para nefropatia membranosa primária

Imported from official source

Announcement

Safety Classified by Officially

Foi aprovada ainda nova indicação terapêutica para medicamento que reduz os níveis de colesterol LDL-C

This is an extract. The publication continues at the source.

Read the original at the source: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-aprova-novo-tratamento-para-nefropatia-membranosa-primaria

Officially imported this from Agência Nacional de Vigilância Sanitária (Anvisa)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Agência Nacional de Vigilância Sanitária (Anvisa) — imported from official source
Official source
https://www.gov.br/anvisa/++api++/@search?portal_type=News%20Item&sort_on=effective&sort_order=reverse&b_size=25&metadata_fields=effective&metadata_fields=UID API
Imported
November 05, 2026 21:00
Versions
1 recorded
Identity
67cf11c7d9cd410a8095111b0fef5013

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.